Save time and get answers to complex questions with AI chat
Mebendazole 100mg price?Albendazole side effects in humans?Patent expiration eu dabrafenib?How does iron rich food intake impact lipitor's efficacy?What excipients are combined with ruxolitinib in apotex's medication?
See the DrugPatentWatch profile for renvela
Renvela (sevelamer) is used to treat high phosphorus levels (hyperphosphatemia) in people with chronic kidney disease (CKD)—especially those who are on dialysis. It helps lower blood phosphate levels by binding phosphate in the gut so the body can get rid of it. [1]
In CKD, the kidneys cannot remove phosphorus well, so phosphate can build up in the blood. High phosphate is linked with complications such as bone disease (from disturbed mineral metabolism) and may contribute to blood vessel and heart problems over time. Renvela is used as part of managing these mineral balance issues in CKD patients. [1]
Renvela is prescribed for CKD patients with hyperphosphatemia, and dosing is typically guided by lab results (phosphate levels). It is commonly used in people receiving dialysis, but the specific patient eligibility depends on the clinician’s assessment and the prescribing information for the product. [1]
Other Questions About Renvela :